Drug Studies

We are proud to offer our patients participation in neurological research in keeping with our mission of providing the most advanced level of care possible.

With offices in Port Royal, Bluffton, and Hampton.

Research Trials

Coastal Neurology is proud to offer our community opportunities to participate in neurological research in keeping with our mission of providing the most advanced level of patient care possible. We have more than 20 years of clinical trial experience. Contact our dedicated research coordinator, Daisy White, at 843.522.1420 for more information.

Research Trials

Coastal Neurology is proud to offer our community opportunities to participate in neurological research in keeping with our mission of providing the most advanced level of patient care possible. We have more than 20 years of clinical trial experience. Contact our dedicated research coordinator, Daisy White, at 843.522.1420 for more information.

Alzheimer’s Disease Research

  • CLARITY-AD: A twice-a-month medication targeting amyloid plaque in mild cognitive impairment and early Alzheimer’s Disease.
  • ICARE-AD: Study of the effectiveness of FDA-approved Aduhelm in the treatment of mild cognitive impairment and early Alzheimer’s Disease.
  • New IDEAS: A study to investigate the value of amyloid PET scans in diagnosing and treating suspected Alzheimer’s Disease.

Other Research

Migraine

  • TRIUMPH: Real world assessment of various preventative therapies for migraine.

Multiple Sclerosis

  • VERISMO: Real world assessment of multiple sclerosis therapies vs. ocrelizumab.

Muscle Spasticity

  • SPAS-201: Botulinum toxin treatment of muscle spasms due to stroke, traumatic brain injury, spinal cord injury or multiple sclerosis

Parkinson’s Disease & Lewy Body Disease

  • APTINYX: An oral medication to treat cognitive impairment in Parkinson’s or Lewy Body Disease